PTE - PolarityTE, Inc.
| Previous Close | 4.4700 |
| Open | 4.5000 |
| Bid | 4.2200 x 1800 |
| Ask | 4.2300 x 800 |
| Day's Range | 4.1700 - 4.5000 |
| 52 Week Range | 4.1700 - 1,231.5300 |
| Volume | 170,045 |
| Avg. Volume | 330,384 |
| Market Cap | 105.955M |
| Beta (3Y Monthly) | 1.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2016-01-12 |
| 1y Target Est | N/A |
- Insider Monkey•24 days ago
Is PolarityTE, Inc. (PTE) A Good Stock To Buy ?
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won't accept your savings unless you commit at least $5 million) by pinpointing […]
- Simply Wall St.•last month
What Type Of Shareholder Owns PolarityTE, Inc.'s (NASDAQ:PTE)?
The big shareholder groups in PolarityTE, Inc. (NASDAQ:PTE) have power over the company. Institutions will often hold...
- Benzinga•last month
PolarityTE Shares Rally On Positive Readout From Skin Graft Study In Diabetic Foot Ulcers
PolarityTE presented final results from a pilot study on the use of its SkinTE product for hard-to-treat diabetic foot ulcers, or DFUs, as a poster, which showed that 10 of the 11 patients evaluated in the study had healed DFUs within eight weeks of SkinTE application, with a mean time to heal of 29.7 days. SkinTE is an autologous, homologous human cellular and tissue-based product capable of regenerating full-thickness, functional skin for the repair, reconstruction and replacement of a patient's own skin. PolaityTE said the abstract will be published in the online supplement to the journal Diabetes later this year.
- Benzinga•last month
Ready Trader One: Events, Stocks To Watch At E3
The 24th Electronic Entertainment Expo (E3) kicks off June 11 in Los Angeles, but the news is already flowing this weekend, with many gaming companies showcasing their biggest announcements and presentations. ...
GuruFocus.com•2 months agoAnalysts Recommend These 3 Falling Knives
The following companies can be considered "falling knives" because their share prices have declined more than 59% over the past 52 weeks through May 30. Wall Street is also optimistic about them as it issued recommendation ratings ranging from overweight to buy with average target prices that produce at least 135% stock appreciation within 52 weeks. Warning! GuruFocus has detected 3 Warning Signs with PTE.
- Zacks•2 months ago
Implied Volatility Surging for PolarityTE (PTE) Stock Options
PolarityTE (PTE) needs investors to pay close attention to the stock based on moves in the options market lately.
- Zacks•2 months ago
3 Small Drug Stocks Poised to Beat Q1 Earnings Estimates
So far this earnings season, the going seems to be good for the medical sector. Let us take a glance at a few small drug companies, which are likely to beat on Q1 earnings.
- Simply Wall St.•3 months ago
Should You Be Concerned About PolarityTE, Inc.'s (NASDAQ:PTE) Historical Volatility?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you're interested in PolarityTE, Inc. (NASDAQ:PTE), then you might want to consider its beta (a me...
- Motley Fool•3 months ago
Why PolarityTE Is Sinking Today
Shares drop after the company announces that it is raising capital. Here are the must-know details for investors.
- Motley Fool•4 months ago
Why PolarityTE Stock Tanked Today
Shares plunge after the company reports fourth-quarter results. Here's what investors need to know.
- CNBC•4 months ago
Biotech's shares tumble after it says SEC is looking into possible manipulation
PolarityTE said the SEC subpoenaed it earlier this month for documents related to any promotion of the company or its securities, among other items.
- Simply Wall St.•4 months ago
Read This Before Buying PolarityTE, Inc. (NASDAQ:PTE) Shares
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examplesRead More...
- Motley Fool•4 months ago
Why PolarityTE Stock Is Shooting Higher Today
Traders cheered after some positive regulatory news emerged.
- Zacks•4 months ago
Will Polarity (PTE) Report Negative Q1 Earnings? What You Should Know
Polarity (PTE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•5 months ago
Zacks.com featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery
Zacks.com featured expert Kevin Matras highlights: Shenandoah Telecommunications, Honda Motor, PolarityTE, Ubiquiti Networks and Titan Machinery
- Zacks•5 months ago
5 Stocks to Buy as New Analysts Initiate Coverage
Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.
- Simply Wall St.•5 months ago
PolarityTE, Inc. (NASDAQ:PTE): The Best Of Both Worlds
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Attractive stocks have exceptional fundamentals. In the Read More...
- Simply Wall St.•7 months ago
Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74%
Today I will be providing a simple run through of a valuation method used to estimate the attractiveness of PolarityTE, Inc. (NASDAQ:PTE) as an investment opportunity by taking the expected Read More...
- Zacks•9 months ago
Moving Average Crossover Alert: PolarityTE (PTE)
PolarityTE, Inc. (PTE) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
- Benzinga•9 months ago
Cool Mara Riot, Part Two: Securities-Fraud Case Against South Florida Group Reverberates Through Additional Companies
EDITOR'S NOTE: The following is an excerpt of part two of an investigation into financier Barry Honig and several associated parties. When financier Barry C. Honig was waging a proxy fight for control of the company that became Riot Blockchain Inc. (NASDAQ: RIOT), he demanded that it return excess capital to shareholders through a special dividend.
